Meet with Flatiron at WCLC to explore how real-world data can help answer critical questions in lung cancer. With data on 345,000+ patients and deep clinical and biomarker detail, Flatiron RWD provides insight into treatment patterns, biomarker-driven care, and real-world outcomes to help you make more confident decisions.
Flatiron Experts
Dionne Ng
Scientific Engagement and Partnerships, Flatiron Health
